EW logo

EW EBITDA

Annual EBITDA:

$1.60B+$27.30M(+1.74%)
December 31, 2024

Summary

  • As of today, EW annual EBITDA is $1.60 billion, with the most recent change of +$27.30 million (+1.74%) on December 31, 2024.
  • During the last 3 years, EW annual EBITDA has fallen by -$174.20 million (-9.82%).
  • EW annual EBITDA is now -14.43% below its all-time high of $1.87 billion, reached on December 31, 2022.

Performance

EW EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

Quarterly EBITDA:

$472.30M+$14.20M(+3.10%)
September 30, 2025

Summary

  • As of today, EW quarterly EBITDA is $472.30 million, with the most recent change of +$14.20 million (+3.10%) on September 30, 2025.
  • Over the past year, EW quarterly EBITDA has increased by +$60.50 million (+14.69%).
  • EW quarterly EBITDA is now -4.28% below its all-time high of $493.40 million, reached on June 30, 2021.

Performance

EW Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

TTM EBITDA:

$1.76B+$60.50M(+3.56%)
September 30, 2025

Summary

  • As of today, EW TTM EBITDA is $1.76 billion, with the most recent change of +$60.50 million (+3.56%) on September 30, 2025.
  • Over the past year, EW TTM EBITDA has increased by +$157.80 million (+9.86%).
  • EW TTM EBITDA is now -5.83% below its all-time high of $1.87 billion, reached on December 31, 2022.

Performance

EW TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EW EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+1.7%+14.7%+9.9%
3Y3 Years-9.8%+0.6%-3.3%
5Y5 Years+21.9%+23.0%+25.9%

EW EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-14.4%+1.7%at high+23.2%-5.8%+11.8%
5Y5-Year-14.4%+21.9%-4.3%+23.2%-5.8%+25.9%
All-TimeAll-Time-14.4%+980.7%-4.3%+1362.2%-5.8%+3723.3%

EW EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$472.30M(+3.1%)
$1.76B(+3.6%)
Jun 2025
-
$458.10M(+5.0%)
$1.70B(+3.4%)
Mar 2025
-
$436.30M(+11.3%)
$1.64B(+2.6%)
Dec 2024
$1.60B(+1.7%)
$392.00M(-4.8%)
$1.60B(-0.1%)
Sep 2024
-
$411.80M(+2.5%)
$1.60B(+1.8%)
Jun 2024
-
$401.70M(+2.0%)
$1.57B(-0.3%)
Mar 2024
-
$394.00M(+0.2%)
$1.58B(-3.1%)
Dec 2023
$1.57B(-15.9%)
$393.40M(+2.6%)
$1.63B(-3.4%)
Sep 2023
-
$383.40M(-5.7%)
$1.69B(-4.8%)
Jun 2023
-
$406.70M(-8.6%)
$1.77B(-3.4%)
Mar 2023
-
$444.80M(-1.5%)
$1.83B(-1.8%)
Dec 2022
$1.87B(+5.4%)
$451.50M(-3.8%)
$1.87B(+2.7%)
Sep 2022
-
$469.30M(0.0%)
$1.82B(+1.2%)
Jun 2022
-
$469.30M(-1.7%)
$1.80B(-1.3%)
Mar 2022
-
$477.50M(+18.8%)
$1.82B(+2.6%)
Dec 2021
$1.77B(+23.9%)
$401.90M(-10.3%)
$1.77B(-0.0%)
Sep 2021
-
$447.90M(-9.2%)
$1.77B(+3.7%)
Jun 2021
-
$493.40M(+14.6%)
$1.71B(+16.4%)
Mar 2021
-
$430.50M(+7.0%)
$1.47B(+2.6%)
Dec 2020
$1.43B(+9.1%)
$402.40M(+4.8%)
$1.43B(+2.5%)
Sep 2020
-
$384.00M(+52.2%)
$1.40B(+5.1%)
Jun 2020
-
$252.30M(-35.8%)
$1.33B(-3.4%)
Mar 2020
-
$392.70M(+6.8%)
$1.38B(+4.9%)
Dec 2019
$1.31B(+12.2%)
$367.60M(+16.1%)
$1.31B(+4.6%)
Sep 2019
-
$316.50M(+6.0%)
$1.25B(+3.5%)
Jun 2019
-
$298.50M(-9.0%)
$1.21B(-0.2%)
Mar 2019
-
$327.90M(+5.8%)
$1.21B(+3.8%)
Dec 2018
$1.17B(+7.1%)
$310.00M(+12.9%)
$1.17B(+4.2%)
Sep 2018
-
$274.60M(-8.9%)
$1.12B(+3.3%)
Jun 2018
-
$301.40M(+6.2%)
$1.09B(+2.6%)
Mar 2018
-
$283.70M(+8.0%)
$1.06B(-4.1%)
Dec 2017
$1.09B(+23.2%)
$262.60M(+10.0%)
$1.10B(+3.2%)
Sep 2017
-
$238.70M(-12.8%)
$1.07B(+2.1%)
Jun 2017
-
$273.70M(-16.7%)
$1.05B(+4.3%)
Mar 2017
-
$328.70M(+44.2%)
$1.00B(+13.8%)
Dec 2016
$886.70M(+38.2%)
$228.00M(+5.1%)
$882.60M(+6.9%)
Sep 2016
-
$217.00M(-5.9%)
$825.70M(+8.1%)
Jun 2016
-
$230.60M(+11.4%)
$763.80M(+12.7%)
Mar 2016
-
$207.00M(+21.0%)
$677.80M(+5.6%)
Dec 2015
$641.70M(+15.5%)
$171.10M(+10.3%)
$641.70M(+0.7%)
Sep 2015
-
$155.10M(+7.3%)
$637.20M(+0.5%)
Jun 2015
-
$144.60M(-15.4%)
$634.20M(+2.0%)
Mar 2015
-
$170.90M(+2.6%)
$622.00M(+11.9%)
Dec 2014
$555.80M(+10.8%)
$166.60M(+9.5%)
$555.80M(+5.6%)
Sep 2014
-
$152.10M(+14.9%)
$526.20M(+8.1%)
Jun 2014
-
$132.40M(+26.5%)
$486.60M(-0.0%)
Mar 2014
-
$104.70M(-23.6%)
$486.80M(-3.0%)
Dec 2013
$501.70M(+10.5%)
$137.00M(+21.8%)
$501.70M(-0.4%)
Sep 2013
-
$112.50M(-15.2%)
$503.50M(+2.0%)
Jun 2013
-
$132.60M(+10.9%)
$493.80M(+5.1%)
Mar 2013
-
$119.60M(-13.8%)
$470.00M(+3.5%)
Dec 2012
$454.00M
$138.80M(+35.0%)
$454.00M(+7.1%)
Sep 2012
-
$102.80M(-5.5%)
$424.00M(+4.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
$108.80M(+5.0%)
$406.60M(+3.0%)
Mar 2012
-
$103.60M(-4.8%)
$394.60M(+1.9%)
Dec 2011
$387.10M(+14.2%)
$108.80M(+27.4%)
$387.10M(+4.2%)
Sep 2011
-
$85.40M(-11.8%)
$371.50M(+2.4%)
Jun 2011
-
$96.80M(+0.7%)
$362.90M(+2.3%)
Mar 2011
-
$96.10M(+3.1%)
$354.80M(+4.7%)
Dec 2010
$339.00M(+16.2%)
$93.20M(+21.4%)
$339.00M(+3.3%)
Sep 2010
-
$76.80M(-13.4%)
$328.20M(+2.4%)
Jun 2010
-
$88.70M(+10.5%)
$320.50M(+5.3%)
Mar 2010
-
$80.30M(-2.5%)
$304.40M(+4.4%)
Dec 2009
$291.70M(+10.2%)
$82.40M(+19.2%)
$291.70M(+4.7%)
Sep 2009
-
$69.10M(-4.8%)
$278.50M(+4.1%)
Jun 2009
-
$72.60M(+7.4%)
$267.50M(+2.3%)
Mar 2009
-
$67.60M(-2.3%)
$261.60M(+3.0%)
Dec 2008
$264.60M(+18.0%)
$69.20M(+19.1%)
$253.90M(+4.1%)
Sep 2008
-
$58.10M(-12.9%)
$243.80M(+3.2%)
Jun 2008
-
$66.70M(+11.4%)
$236.30M(+2.6%)
Mar 2008
-
$59.90M(+1.4%)
$230.40M(+1.3%)
Dec 2007
$224.30M(+1.8%)
$59.10M(+16.8%)
$227.40M(+0.6%)
Sep 2007
-
$50.60M(-16.8%)
$226.00M(-1.5%)
Jun 2007
-
$60.80M(+6.9%)
$229.50M(+0.4%)
Mar 2007
-
$56.90M(-1.4%)
$228.60M(-0.7%)
Dec 2006
$220.30M(-5.0%)
$57.70M(+6.7%)
$230.10M(-1.7%)
Sep 2006
-
$54.10M(-9.7%)
$234.00M(+1.9%)
Jun 2006
-
$59.90M(+2.6%)
$229.60M(+3.7%)
Mar 2006
-
$58.40M(-5.2%)
$221.50M(+1.1%)
Dec 2005
$231.80M(+10.3%)
$61.60M(+23.9%)
$219.00M(+3.4%)
Sep 2005
-
$49.70M(-4.1%)
$211.80M(-0.4%)
Jun 2005
-
$51.80M(-7.3%)
$212.70M(-0.7%)
Mar 2005
-
$55.90M(+2.8%)
$214.30M(+2.1%)
Dec 2004
$210.10M(+14.2%)
$54.40M(+7.5%)
$209.90M(+1.8%)
Sep 2004
-
$50.60M(-5.2%)
$206.20M(+3.4%)
Jun 2004
-
$53.40M(+3.7%)
$199.40M(+4.0%)
Mar 2004
-
$51.50M(+1.6%)
$191.70M(+4.2%)
Dec 2003
$184.00M(+20.9%)
$50.70M(+15.8%)
$184.00M(+5.0%)
Sep 2003
-
$43.80M(-4.2%)
$175.30M(+4.5%)
Jun 2003
-
$45.70M(+4.3%)
$167.80M(+5.4%)
Mar 2003
-
$43.80M(+4.3%)
$159.20M(+4.6%)
Dec 2002
$152.20M(+2.8%)
$42.00M(+15.7%)
$152.20M(+1.3%)
Sep 2002
-
$36.30M(-2.2%)
$150.20M(+2.7%)
Jun 2002
-
$37.10M(+0.8%)
$146.20M(-2.3%)
Mar 2002
-
$36.80M(-8.0%)
$149.60M(-1.7%)
Dec 2001
$148.00M(-4.5%)
$40.00M(+23.8%)
$152.20M(-1.4%)
Sep 2001
-
$32.30M(-20.2%)
$154.40M(-6.9%)
Jun 2001
-
$40.50M(+2.8%)
$165.90M(+2.2%)
Mar 2001
-
$39.40M(-6.6%)
$162.40M(-3.9%)
Dec 2000
$155.00M(-2.5%)
$42.20M(-3.7%)
$169.00M(+33.3%)
Sep 2000
-
$43.80M(+18.4%)
$126.80M(+52.8%)
Jun 2000
-
$37.00M(-19.6%)
$83.00M(+80.4%)
Mar 2000
-
$46.00M
$46.00M
Dec 1999
$159.00M(-5.9%)
-
-
Dec 1998
$169.00M(-14.6%)
-
-
Dec 1997
$198.00M
-
-

FAQ

  • What is Edwards Lifesciences Corporation annual EBITDA?
  • What is the all-time high annual EBITDA for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation annual EBITDA year-on-year change?
  • What is Edwards Lifesciences Corporation quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation quarterly EBITDA year-on-year change?
  • What is Edwards Lifesciences Corporation TTM EBITDA?
  • What is the all-time high TTM EBITDA for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation TTM EBITDA year-on-year change?

What is Edwards Lifesciences Corporation annual EBITDA?

The current annual EBITDA of EW is $1.60B

What is the all-time high annual EBITDA for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high annual EBITDA is $1.87B

What is Edwards Lifesciences Corporation annual EBITDA year-on-year change?

Over the past year, EW annual EBITDA has changed by +$27.30M (+1.74%)

What is Edwards Lifesciences Corporation quarterly EBITDA?

The current quarterly EBITDA of EW is $472.30M

What is the all-time high quarterly EBITDA for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high quarterly EBITDA is $493.40M

What is Edwards Lifesciences Corporation quarterly EBITDA year-on-year change?

Over the past year, EW quarterly EBITDA has changed by +$60.50M (+14.69%)

What is Edwards Lifesciences Corporation TTM EBITDA?

The current TTM EBITDA of EW is $1.76B

What is the all-time high TTM EBITDA for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high TTM EBITDA is $1.87B

What is Edwards Lifesciences Corporation TTM EBITDA year-on-year change?

Over the past year, EW TTM EBITDA has changed by +$157.80M (+9.86%)
On this page